A Ten-year Report of Drug and Poison Information Center in Mashhad, Iran 2007-2017

Document Type : Research article

Authors

1 Department of Clinical Pharmacy, School of Pharmacy, Mashhad University of Medical Science, Mashhad, Iran.

2 Department of Community Health and Epidemiology, College of Medicine, University of Saskatchewan, Saskatoon, SK, Canada.

3 Department of Biostatistics, School of Health, Mashhad University of Medical Science, Mashhad, Iran.

4 Pharmaceutical Research Center, Faculty of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran.

5 Research and Development Center, Food and Drug Administration, Mashhad University of Medical Sciences, Mashhad, Iran.

Abstract

The Mashhad drug and poison information center (MDPIC) was officially established in 2000 to provide up-to-date information on medications. The objective of this study is to provide an epidemiologic profile of drug inquiry and poisoning-related phone calls to MDPIC from 2007 to 2017. This article is a descriptive retrospective study in which all inquiries about drugs and poisoning cases received by MDPIC, from 1st January 2007 to 31st December 2017, were retrieved from its database for analysis.
A total of 100997 cases were analyzed. The most frequent calls were from individuals in the age group of 18 to 60 years old (70.21%). The majority of callers were women (73.08%). The public made 95.11% of calls, and 4.89% were related to health care professionals. The queries were mainly related to therapeutic uses of drugs (24.03%), followed by adverse drug reactions (18.96%). Given that 99.23% of calls were related to drug information inquiries, the most common drugs questioned about were antimicrobial (12.3%) and vitamin and minerals (10.76%), whereas 0.77% of calls were about poisoning and the majority of them were due to drugs poisoning. Micromedex® was the most commonly used reference to answer the inquiries. This report shows an updated epidemiological evaluation on recorded calls in the drug and poison information center in Mashhad. Since there is no other similar report, this can provide valuable information on the trend of drug usage and may guide further strategies in giving proper information to public and health centers.

Graphical Abstract

A Ten-year Report of Drug and Poison Information Center in Mashhad, Iran 2007-2017

Keywords


 (1) Almazrou DA, Ali S and Alzhrani JA. Assessment of Queries Received by the Drug Information Center at King Saud Medical City. J. Pharm. Bioallied Sci.n(2017) 9: 246-50.
(2) Tarn DM, Heritage J, Paterniti DA, Hays RD, Kravitz RL and Wenger NS. Physician communication when prescribing new medications.
Int. Arch. Intern. Med. (2006) 166: 1855-62.
(3) Vainio KK, Airaksinen MS, Hyykky TT and Enlund KH. Effect of therapeutic class on conunseling in community pharmacies.
Ann. Pharmacother. (2002) 36: 781-6.
(4) Karimi G, Nazemian L, Soodmand N, Ghorbani M, Behravan E and Taghiabadi E. Mashhad Drug And Poison Information Center: Annual Report 2008.
Pharmacologyonline (2009) 2: 53-962.
(5) Ghane T, Behmanesh Y and Khazei F. Annual Report of Drug and Poison Information in Iran From March 2012 to March 2013.
Acta Med. Iranica (2016) 54: 525-9.
(6) Hall V, Gomez C, and Fernandez-Llimos F. Situation of drug information centers and services in Costa Rica.
Pharm. Pract. (2006) 4: 1-7.  
(7) Markind JE and Stachnik JM. European drug information centers. J. Hum. Lact. (1996) 12: 239-42.
(8) Pohjanoksa-Mantyla MK, Antila J, Eerikainen S, Enakoski M, Hannuksela O, Pietila K and Airaksinen M. Utilization of a community pharmacy-operated national drug information call center in Finland.
Res. Social Adm. Pharm. (2008) 4: 144-52.
(9) Shadnia S, Soltaninejad K, Sohrabi F, Rezvani M, Barari B and Abdollahi M. The performance of loghman-hakim drug and poison information center from 2006 to 2008.
Iran. J. Pharm. Res. (2011) 10: 647-52.
(10) Bond C, Raehl CL and Franke T. Clinical pharmacy services, hospital pharmacy staffng, and medication errors in United States hospitals.
Pharmacotherapy (2002) 22: 134-47.
(11) Entezari-Maleki T, Taraz M, Javadi MR, Hajimiri MH, Eslami K, Karimzadeh I, Esmaeili M and Gholami K. A two-year utilization of the pharmacistoperated drug information center in Iran.
J. Res. Pharm. Pract. (2014) 3: 117-22.
(12) Oder M and Põld K. Estonian experience on establishment of a modern national poison information centre: one-year profle of phone calls in 2012.
Asia Pac. J. Med. Toxicol. (2013) 2: 42-7.
(13) Vassilev ZP, Chu AF, Ruck B, Adams EH and Marcus SM. Evaluation of adverse drug reactions reported to a poison control center between 2000 and 2007.
Am. J. Health Syst. Pharm. (2009) 66: 481-7.
(14) Churi S, Abraham L, Ramesh M and Narahari MG. Evaluation of poison information services provided by a new poison information center.
Indian J. Pharmacol. (2013) 45: 496-501.
(15) Ponampalam R and Loh C. Cost benefts of the Drug and Poison Information Centre in preventing unnecessary hospitalisation: The Singapore experience.
Hong Kong J. Emerg. Med. (2010) 17:45-53.
(16) Hands D, Stephens M and Brown D. A systematic review of the clinical and economic impact of drug information services on patient outcome.
Pharm. Pharm. Sci. (2002) 24: 132-8.
(17) Beaird S, Coley R and Crea K. Current status of drug information centers.
Am. J. Health. Syst. Pharm.(1992) 49: 103-6.
(18) Burkholder DF. Some experiences in the establishment and operation of a drug information center.
Am. J. Hosp. Pharm. (1963) 20: 507-13.
(19) Rosenberg JM, Koumis T, Nathan JP, Cicero LA and Mcguire H. Current status of pharmacist-operated drug information centers in the United States.
Am. J. Health. Syst. Pharm. (2004) 61: 2023-32.
(20) Ghane T, Behmanesh Y and Khazaei F. Annual report of recorded phone calls to Iran’s drug and poison information centers (2014-2015).
Asia Pac. J. Med. Toxicol. (2015) 4: 97-101.
(21) Health Information Exchange System 2018 Available from: URL: https://pharmacy.fda.gov.ir/nemayeshZarfatShahrSearch.
(22) Bouvy ML, Meijboom RH, Van Berkel J and de Roos-Huisman CM. Patients’ drug-information needs: a brief view on questions asked by telephone and on the Internet.
Pharm. Pharm. Sci. (2002) 24:43-5.
(23) Karimzadeh I, Vazin A, Talebnia N, HatamiMazinani N and Mahi-Birjand M. Performance of drug and poison information center within a referral university hospital in southwest of Iran.
J. Pharm. Care. (2018) 5: 49-55.
(24) Lazarou J, Pomeranz BH and Corey PN. Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies.
JAMA (1998) 279: 1200-5.
(25) Riedl MA and Casillas AM. Adverse drug reactions: types and treatment options.
Am. Fam. Physician. (2003) 68: 1781-90.
(26) Col NF and O’Connor RW. Estimating worldwide current antibiotic usage: report of Task Force 1.
Rev. Infect. Dis. (1987) 9: S232-S43.
(27) Cheraghali A, Nikfar S, Behmanesh Y, Rahimi V, Habibipour F, Tirdad R, Asadi A and Bahrami A. Evaluation of availability, accessibility and prescribing pattern of medicines in the Islamic Republic of Iran.
East. Mediterr. Health J. (2004) 10: 406-15.
(28) Afshari R, Majdzadeh R and Balai
Mood M. Pattern of acute poisonings in Mashhad, Iran 1993–2000. J. Toxicol. Clin. Toxicol. (2004) 42: 965-75.
(29) Khadem Rezaiyan M and Afshari R. Epidemiology of poisoning in northeast of Iran (2004-2013).
Int. J. Med. Toxicol. Forensic. Med. (2017) 7: 54-8.
(30) Ghane T, Saberi S and Davoodabadi M. Descriptive analysis of recorded phone calls to Iran drug and poison information centers during 2011-2012.
Asia Pac. J. Med. Toxicol. (2013) 2: 48-51.
(31) Nikfar S, Abdollahi M and Cheraghali A. Going from strength to strength; a drug and poison information centre.
Essent. Drugs Monit. (2000) 28: 30-1.
(32) Azami-Aghdash S, Mohseni M, Etemadi M, Royani S, Moosavi A and Nakhaee M. Prevalence and cause of self medication in Iran: a systematic review and meta-analysis article.
Iran. J. Public Health (2015) 44: 1580-93.
(33) Mowry JB, Spyker DA, Brooks DE, Zimmerman A and Schauben JL. 2015 Annual Report of the American Association of Poison Control Centers
  National Poison Data System (NPDS): 33rd Annual Report. Clin. Toxicol. (2016) 54: 924-1109.
(34) Goto K, Kuroki Y, Shintani S and Kusakawa S. Accidental poisoning of children in Japan: A report from the Japan Poison Information Center.
Acta Paediatr. Jpn. (1993) 35: 193-200.
(35) Zargarzadeh AH, Minaeiyan M and Torabi A. Prescription and nonprescription drug use in Isfahan, Iran: an observational, cross-sectional study.
Curr. Ther. Res. (2008) 69: 76-87.
(36) Asiri YA, Al-Arif MN, Al-Sultan MS and Gubara OA. Evaluation of drug and poison information center in Saudi Arabia during the period 2000-2002.
Saudi Med. J. (2007) 28: 617-9.
(37) Mountford CM, Lee T, de Lemos J and Loewen PS. Quality and usability of common drug information databases.
Can. J. Hosp. Pharm. (2010) 63: 130.